Papers
14
Total Citations
136
H-Index
6
About
See-Tong Pang is a leading urologic surgeon and researcher whose work centers on advancing robotic-assisted surgery for prostate and kidney cancers, with a particular focus on improving patient quality of life. His major contributions include developing modified pelvic floor muscle training that significantly reduces post-prostatectomy urinary incontinence while also alleviating depression and anxiety—a study cited 48 times. Pang has pioneered the use of indocyanine green fluorescence in robot-assisted partial nephrectomy (18 citations) to enhance surgical precision and nephron sparing. He has also integrated artificial intelligence into postoperative care, creating a deep learning model that rapidly predicts urinary incontinence recovery from cystography features. His comparative research on 68Ga-PSMA-11 PET/CT versus multiparametric MRI for detecting biochemical recurrence (16 citations) has refined imaging protocols for prostate cancer surveillance. Notably, Pang’s investigation into periprostatic adipose tissue revealed a surprising protective role, where fat cells secrete apoptotic factors that inhibit tumor progression during early-stage disease. With over 120 cumulative citations across his top papers, Pang’s work bridges surgical innovation, functional outcomes, and tumor biology, establishing him as a transformative figure in robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Robot-assisted laparoendoscopic single site adrenalectomy14 citations · 2017
- 5
- 6
- 7
- 8
- 9
- 10